AstraZeneca PLC (AZN)
68.54
+0.18
(+0.26%)
USD |
NASDAQ |
Apr 19, 16:00
68.57
+0.03
(+0.04%)
After-Hours: 17:22
AstraZeneca Gross Profit Margin (Quarterly): 80.81% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 80.81% |
| September 30, 2023 | 81.77% |
| June 30, 2023 | 82.83% |
| March 31, 2023 | 82.49% |
| December 31, 2022 | 74.12% |
| September 30, 2022 | 72.85% |
| June 30, 2022 | 72.17% |
| March 31, 2022 | 69.17% |
| December 31, 2021 | 61.49% |
| September 30, 2021 | 61.92% |
| June 30, 2021 | 73.35% |
| March 31, 2021 | 74.54% |
| December 31, 2020 | 79.42% |
| September 30, 2020 | 79.17% |
| June 30, 2020 | 84.32% |
| March 31, 2020 | 77.65% |
| December 31, 2019 | 79.32% |
| September 30, 2019 | 78.91% |
| June 30, 2019 | 81.74% |
| March 31, 2019 | 79.44% |
| December 31, 2018 | 74.49% |
| September 30, 2018 | 78.41% |
| June 30, 2018 | 80.37% |
| March 31, 2018 | 78.10% |
| December 31, 2017 | 78.80% |
| Date | Value |
|---|---|
| September 30, 2017 | 79.96% |
| June 30, 2017 | 81.19% |
| March 31, 2017 | 83.46% |
| December 31, 2016 | 79.23% |
| September 30, 2016 | 84.21% |
| June 30, 2016 | 81.05% |
| March 31, 2016 | 83.58% |
| December 31, 2015 | 80.17% |
| September 30, 2015 | 82.49% |
| June 30, 2015 | 83.08% |
| March 31, 2015 | 79.05% |
| December 31, 2014 | 75.18% |
| September 30, 2014 | 78.59% |
| June 30, 2014 | 80.67% |
| March 31, 2014 | 77.51% |
| December 31, 2013 | 79.25% |
| September 30, 2013 | 80.19% |
| June 30, 2013 | 78.87% |
| March 31, 2013 | 80.17% |
| December 31, 2012 | 80.80% |
| September 30, 2012 | 80.93% |
| June 30, 2012 | 79.79% |
| March 31, 2012 | 81.29% |
| December 31, 2011 | 81.38% |
| September 30, 2011 | 80.60% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
61.49%
Minimum
Dec 2021
84.32%
Maximum
Jun 2020
76.21%
Average
78.91%
Median
Sep 2019
Gross Profit Margin (Quarterly) Benchmarks
| GSK PLC | 69.97% |
| Amgen Inc | 62.03% |
| Gilead Sciences Inc | 70.62% |
| Viking Therapeutics Inc | -- |
| Fusion Pharmaceuticals Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.95% |
| Return on Assets | 6.12% |
| Return on Invested Capital | 9.04% |
| Profit Margin (Quarterly) | 7.98% |
| Operating Margin (Quarterly) | 16.67% |
| Return on Net Operating Assets | 6.94% |